Keytruda cleared for frontline lung cancer in England - but only after another pricing deal

07:20 EDT 6 Jun 2018 | PMLIVE

Keytruda first drug to exit Cancer Drugs Fund and go through Budget Impact Test

More From BioPortfolio on "Keytruda cleared for frontline lung cancer in England - but only after another pricing deal"